3 min read
Measuring What Can't Be Seen: How PTSD Clinical Trials Prove a Drug Works
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...
Veristat is excited to join clinical research professionals to discuss the key challenges faced by small to mid-sized biotech and pharma companies at the Outsourcing in Clinical Trials Southeast 2017 event. Speaking topics will span both clinical outsourcing and clinical operations challenges such as vendor sourcing, contract development, regulatory compliance, patient enrollment, budget adherence and more.
The conference will cover many exciting topics including:
Outsourcing in Oncology – Overcoming Common Pitfalls and Celebrating Success
Considering adaptive design when outsourcing studies to vendors to improve decision making throughout phases
Considering patient and site perspectives when designing a study to increase enrollment and retention rates
Meet up with Veristat while you are at OCT Southeast! Don’t forget to stop by our booth #8 to meet with our experts to talk about the challenges you are facing with your clinical trial design, execution and regulatory submission projects.
Fill out the form on the right to schedule a specific time to meet with Jessica Young or Derek Luther at the conference.
3 min read
Apr 27, 2026 Veristat Blog
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...
3 min read
Apr 24, 2026 Veristat Blog
In August 2024, the FDA declined to approve MDMA-assisted therapy for post-traumatic stress disorder. The decision...